𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The US Multicenter Double-Blind, Randomized, Phase III Trial of thymoglobulin versus Atgam in the treatment of acute graft rejection episodes following renal transplantation: rationale for study design

✍ Scribed by T.J Schroeder; L.W Moore; L.W Gaber; A.O Gaber; M.R First

Book ID
117238005
Publisher
Elsevier Science
Year
1999
Tongue
English
Weight
77 KB
Volume
31
Category
Article
ISSN
0041-1345

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Rationale and design of the RIACT–study:
Rationale and design of the RIACT–study: a multi-center placebo controlled double blind study to test the efficacy of RItuximab in Acute Cellular tubulointerstitial rejection with B-cell infiltrates in renal Transplant patients: study protocol for a randomized controlled trial
✍ Lena Schiffer, Mario Schiffer, Saskia Merkel, Anke Schwarz, Michael Mengel, Chri πŸ“‚ Article πŸ“… 2012 πŸ› BioMed Central 🌐 English βš– 454 KB
Treatment Rationale Study Design for the
Treatment Rationale Study Design for the MetLung Trial: A Randomized, Double-Blind Phase III Study of Onartuzumab (MetMAb) in Combination With Erlotinib Versus Erlotinib Alone in Patients Who Have Received Standard Chemotherapy for Stage IIIB or IV Met-Positive Non–Small-Cell Lung Cancer
✍ David R. Spigel; Martin J. Edelman; Tony Mok; Kenneth O'Byrne; Luis Paz-Ares; We πŸ“‚ Article πŸ“… 2012 πŸ› CIG Media Group, LP. 🌐 English βš– 255 KB
Rationale and design of the dual antipla
Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions
✍ Laura Mauri; Dean J. Kereiakes; Sharon-Lise T. Normand; Stephen D. Wiviott; Davi πŸ“‚ Article πŸ“… 2010 πŸ› Elsevier Science 🌐 English βš– 307 KB